Tatva Chintan Pharma Chem Limited (TATVA) — Capital Reinvestment Ratio
Tatva Chintan Pharma Chem Limited (TATVA) has a Capital Reinvestment Ratio of 3.09x as of March 2025, meaning it reinvests 3% of its operating cash flow (Rs246.71 Million) in capital expenditures (Rs762.72 Million). See TATVA net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tatva Chintan Pharma Chem Limited Capital Reinvestment Ratio (2018–2025)
This chart tracks Tatva Chintan Pharma Chem Limited's Capital Reinvestment Ratio across 8 annual periods. Check total reinvestment intensity of Tatva Chintan Pharma Chem Limited to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Tatva Chintan Pharma Chem Limited (2018–2025)
Year-by-year Capital Reinvestment Ratio for Tatva Chintan Pharma Chem Limited from 2018 to 2025. For live market cap and broader valuation context, see how much is Tatva Chintan Pharma Chem Limited worth.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.09x | Rs246.71 Million | Rs762.72 Million | ▲ +135.9% |
| 2024 | 1.31x | Rs980.44 Million | Rs1.29 Billion | ▼ -82.1% |
| 2023 | 7.31x | Rs277.83 Million | Rs2.03 Billion | ▲ +67.1% |
| 2022 | 4.38x | Rs203.78 Million | Rs891.57 Million | ▲ +407.4% |
| 2021 | 0.86x | Rs243.19 Million | Rs209.70 Million | ▼ -54.7% |
| 2020 | 1.90x | Rs253.12 Million | Rs481.72 Million | ▲ +43.1% |
| 2019 | 1.33x | Rs73.56 Million | Rs97.86 Million | ▼ -54.5% |
| 2018 | 2.93x | Rs104.12 Million | Rs304.61 Million | — |